Profile
Roderike Pohl was Vice President-Research for Biodel, Inc. from December 2003 to December 13, 2008.
He was a Scientific Consultant for Steiner Ventures LLC from August 2003 to November 2003.
Dr. Pohl was Vice President of Preclinical Research MannKind Corporation from December 1998 to July 2003.
He received a PhD from the University of Connecticut.
Former positions of Roderike Pohl
| Companies | Position | End |
|---|---|---|
Biodel, Inc.
 Biodel, Inc. Pharmaceuticals: MajorHealth Technology Biodel, Inc. is a pharmaceutical company, which develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. The company develops product candidates by applying formulation technologies to existing drugs in order to improve their therapeutic profiles. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT. | Chief Tech/Sci/R&D Officer | 2008-12-12 |
| Pharmaceutical Discovery Corp. | Chief Tech/Sci/R&D Officer | 2003-06-30 |
Training of Roderike Pohl
| University of Connecticut | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Biodel, Inc.
Biodel, Inc. Pharmaceuticals: MajorHealth Technology Biodel, Inc. is a pharmaceutical company, which develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. The company develops product candidates by applying formulation technologies to existing drugs in order to improve their therapeutic profiles. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT. | Health Technology |
| Pharmaceutical Discovery Corp. | Health Technology |
- Stock Market
- Insiders
- Roderike Pohl
